With all the uncertainty of COVID-19, we hope you are safe and in good health. Ozgene is still here to meet your research needs.

Evidence That Cd101 Is an Autoimmune Diabetes Gene in Nonobese Diabetic Mice.

 Back to publications

2011

J Immunol 2011 Jul 1;187(1):325-36. Epub 2011 May

Evidence That Cd101 Is an Autoimmune Diabetes Gene in Nonobese Diabetic Mice.

Bluestone, JA;Burren, O;Christensen, M;Clark, J;Finger, EB;Fraser, HI;Fusakio, ME;Houchins, JP;Howlett, SK;Koentgen, F;Masteller, EL;Mattner, J;Mohammed, JP;Moody, V;Moule, C;Naf, D;Peterson, LB;Rainbow, DB;Ridgway, WM;Steward, CA;Todd, JA;Wicker, LS

Juvenile Diabetes Research Foundation/Wellcome Trust Diabetes and Inflammation Laboratory, Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom.

Service type: Knockout mice

Abstract

We have previously proposed that sequence variation of the CD101 gene between NOD and C57BL/6 mice accounts for the protection from type 1 diabetes (T1D) provided by the insulin-dependent diabetes susceptibility region 10 (Idd10), a <1 Mb region on mouse chromosome 3. In this study, we provide further support for the hypothesis that Cd101 is Idd10 using haplotype and expression analyses of novel Idd10 congenic strains coupled to the development of a CD101 knockout mouse. Susceptibility to T1D was correlated with genotype-dependent CD101 expression on multiple cell subsets, including Foxp3(+) regulatory CD4(+) T cells, CD11c(+) dendritic cells, and Gr1(+) myeloid cells. The correlation of CD101 expression on immune cells from four independent Idd10 haplotypes with the development of T1D supports the identity of Cd101 as Idd10. Because CD101 has been associated with regulatory T and Ag presentation cell functions, our results provide a further link between immune regulation and susceptibility to T1D.

View Publication